Menu
27/02/2002
Eye care company creates 30 jobs in Waterford
Bausch & Lomb, a global eye care company, is to create 30 new jobs at its Waterford operation following the announcement of a £10.5 million investment in the site.
The company will develop the site in order to facilitate the pre-market development and production of its Envision TD drug-delivery system.
Ireland's Investment Development Agency has announced they will provide a slice of the £10.5 million investment total.
Construction is to begin immediately on the addition to the Bausch & Lomb complex that already employs 1800 people in the Waterford area.
The Envision TD drug-delivery system is a tiny implant – about the size of a grain of rice – that is infused with medicine and designed to release therapeutic levels of medicine in a steady, sustained-released flow directly inside the eye for up to three years. It is inserted into the back of the eye in a relatively simple outpatient surgical procedure.
The Envision TD drug-delivery system using the well-known anti-inflammatory drug fluocinolone acetonide is currently in late-stage clinical trials for the treatment of posterior uveitis and diabetic macular edema in the US, Europe and Japan.
Clinical trials for age-related macular degeneration began in January 2002.
(GMcG)
The company will develop the site in order to facilitate the pre-market development and production of its Envision TD drug-delivery system.
Ireland's Investment Development Agency has announced they will provide a slice of the £10.5 million investment total.
Construction is to begin immediately on the addition to the Bausch & Lomb complex that already employs 1800 people in the Waterford area.
The Envision TD drug-delivery system is a tiny implant – about the size of a grain of rice – that is infused with medicine and designed to release therapeutic levels of medicine in a steady, sustained-released flow directly inside the eye for up to three years. It is inserted into the back of the eye in a relatively simple outpatient surgical procedure.
The Envision TD drug-delivery system using the well-known anti-inflammatory drug fluocinolone acetonide is currently in late-stage clinical trials for the treatment of posterior uveitis and diabetic macular edema in the US, Europe and Japan.
Clinical trials for age-related macular degeneration began in January 2002.
(GMcG)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
23 March 2017
TfL Slammed For Turning A 'Blind Eye' To Licensing Rules
GMB London called on Transport for London (TfL) to address the issue of two TfL licensed drivers who have had their licenses revoked by Southend-on-Sea borough council after being found guilty of criminality in 2010.
TfL Slammed For Turning A 'Blind Eye' To Licensing Rules
GMB London called on Transport for London (TfL) to address the issue of two TfL licensed drivers who have had their licenses revoked by Southend-on-Sea borough council after being found guilty of criminality in 2010.
21 March 2006
Actel Opens European Processor R&D Centre in Dublin
Minister for Enterprise, Trade and Employment Micheál Martin announced that Actel Corporation, the California-based leader in single-chip programmable logic solutions, has established a European Processor Development Centre in Dublin with the support of IDA Ireland.
Actel Opens European Processor R&D Centre in Dublin
Minister for Enterprise, Trade and Employment Micheál Martin announced that Actel Corporation, the California-based leader in single-chip programmable logic solutions, has established a European Processor Development Centre in Dublin with the support of IDA Ireland.
-
Northern Ireland WeatherToday:A dry and sunny start but cloud bubbling up with a few showers developing from late morning. Becoming dry and sunny along the east coast in the afternoon. Maximum temperature 12 °C.Tonight:Showers gradually die out to leave good clear spells in the evening and overnight. This will allow a few fog patches to develop in places. Minimum temperature 2 °C.
